| Thomas Obisesan, MD | |
|
2041 Georgia Ave Nw, Washington, DC 20060-0001 | |
| (202) 865-3290 | |
| (202) 865-3833 |
| Full Name | Thomas Obisesan |
|---|---|
| Gender | Male |
| Speciality | Geriatric Medicine |
| Experience | 38 Years |
| Location | 2041 Georgia Ave Nw, Washington, District Of Columbia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295894426 | NPI | - | NPPES |
| 758141601 | Medicaid | MD | |
| 010015413 | Medicaid | VA | |
| 023971400 | Medicaid | DC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | MD19950 (District Of Columbia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Howard University Hospital | Washington, DC | Hospital |
| Washington Ctr For Aging Svcs | Washington, DC | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Howard University | 0941109565 | 136 |
News Archive
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).
In last night's State of the Union address, President Barack Obama offered his take on how the U.S. budget could achieve "fiscal stability" through a mix of Medicare cuts and tax increases; however, he provided few details of what changes to Medicare he found acceptable.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
› Verified 8 days ago
| Entity Name | Howard University |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033163597 PECOS PAC ID: 0941109565 Enrollment ID: O20040102000561 |
News Archive
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).
In last night's State of the Union address, President Barack Obama offered his take on how the U.S. budget could achieve "fiscal stability" through a mix of Medicare cuts and tax increases; however, he provided few details of what changes to Medicare he found acceptable.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Thomas Obisesan, MD 2041 Georgia Ave Nw Tower 6101, Washington, DC 20060-0001 Ph: () - | Thomas Obisesan, MD 2041 Georgia Ave Nw, Washington, DC 20060-0001 Ph: (202) 865-3290 |
News Archive
A new study published in the March 2020 issue of the journal Experimental Results reports that based on data from over 6,500 subjects, the commonly used AQ10 test is not relevant in diagnosing autism. That means a re-examination of the approach used at present to pick up this condition in the population at large is needed. It also means there is a question mark on the validity of research based on this test.
ImmunoGen, Inc., a biotechnology company that develops antibody-based targeted anticancer products, today announced that the US Food and Drug Administration (FDA) has granted orphan drug designation to its lorvotuzumab mertansine (formerly IMGN901) product candidate when used for the treatment of small-cell lung cancer (SCLC).
In last night's State of the Union address, President Barack Obama offered his take on how the U.S. budget could achieve "fiscal stability" through a mix of Medicare cuts and tax increases; however, he provided few details of what changes to Medicare he found acceptable.
A personalized approach to cancer treatment has become more common over the last several decades, with numerous targeted drugs approved to treat particular tumor types with specific mutations or patterns.
› Verified 8 days ago
Dr. Adefolaju Oketokun, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1629 K Street Nw, Suite 300, Washington, DC 20006 Phone: 202-636-1360 Fax: 202-636-5137 | |
Dr. Uzoamaka Theodora Nwaogwugwu, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 2041 Georgia Avenue Nw, Washington, DC 20060 Phone: 202-865-7677 | |
Ms. Sruthi Nukalapati Reddy, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Road Nw, 6 Phc, Washington, DC 20007 Phone: 202-444-8123 | |
Dr. Kaustubh Subhash Yadwadkar, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 3800 Reservoir Rd Nw, Cg201, Washington, DC 20007 Phone: 304-206-7595 | |
Dr. Monica Vohra, M.D. Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 1525 7th St Nw, Washington, DC 20001 Phone: 202-386-7020 Fax: 202-265-1970 | |
Anteneh A Tesfaye, MD Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 110 Irving St Nw Ste C2151, Washington, DC 20010 Phone: 202-877-6998 Fax: 202-877-8909 | |
Erica Nakajima, Geriatric Medicine Medicare: Accepting Medicare Assignments Practice Location: 5255 Loughboro Rd Nw Fl 1, Washington, DC 20016 Phone: 202-660-6500 |